Skip to content

Regeneron Pharmaceuticals Inc. v. Merus N.V.

Petition for certiorari denied on October 1, 2018

Docket No. Argument Opinion Vote Author Term
17-1616 N/A N/A N/A N/A OT 2018

Issue: Whether a patent right can be fully extinguished based on misconduct committed by the patentee"s counsel during federal district court litigation to enforce the patent right.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
03/07/2018Application (17A945) to extend the time to file a petition for a writ of certiorari from March 26, 2018 to May 25, 2018, submitted to The Chief Justice.
03/08/2018Application (17A945) granted by The Chief Justice extending the time to file until May 25, 2018.
05/25/2018Petition for a writ of certiorari filed. (Response due July 2, 2018)
06/01/2018Waiver of right of respondent Merus N.V. to respond filed.
06/05/2018DISTRIBUTED for Conference of 6/21/2018.
06/08/2018Response Requested. (Due July 9, 2018)
06/19/2018Motion to extend the time to file a response from July 9, 2018 to August 8, 2018, submitted to The Clerk.
06/20/2018Motion to extend the time to file a response is granted and the time is extended to and including August 8, 2018.
06/29/2018Brief amicus curiae of New York Intellectual Property Law Association in support of neither Party Filed.
07/09/2018Brief amicus curiae of Intellectual Property Law Association of Chicago filed.
07/09/2018Brief amicus curiae of National Association of Patent Practitioners in support of neither party filed.
07/09/2018Motion for leave to file amici brief filed by Seven Chicago Patent Lawyers.
07/09/2018Brief amicus curiae of Washington Legal Foundation filed.
08/08/2018Brief of respondent Merus N.V. in opposition filed.
08/21/2018Reply of petitioner Regeneron Pharmaceuticals, Inc. filed.
08/22/2018DISTRIBUTED for Conference of 9/24/2018.
10/01/2018Motion for leave to file amici brief filed by Seven Chicago Patent Lawyers GRANTED.
10/01/2018Petition DENIED.